×
About 1,870 results

ALLMedicine™ Genital Warts Center

Research & Reviews  509 results

Epidemiological impact of the human papillomavirus vaccination program on genital warts...
https://doi.org/10.1016/j.vaccine.2021.11.070
Vaccine Fernandes C, Alves J et. al.

Dec 27th, 2021 - The quadrivalent human papillomavirus (HPV) vaccine was introduced in the Portuguese National Immunization Program in October 2008, targeting 13-year-old girls. This study aimed at evaluating the impact of HPV vaccination on the epidemiology of ge...

Psychological aftermath of giant genital warts in a "victim" of the anti-immunisation t...
https://doi.org/10.1080/01443615.2021.1979949
Journal of Obstetrics and Gynaecology : the Journal of Th... Liberis A, Pratilas G et. al.

Dec 16th, 2021 - Psychological aftermath of giant genital warts in a "victim" of the anti-immunisation trend.|2021|Liberis A,Pratilas G,Dampali R,Vatopoulou A,Petousis S,|

Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study
https://clinicaltrials.gov/ct2/show/NCT05149248

Dec 8th, 2021 - Men who have sex with men (MSM), people with HIV, homeless people (many of whom participate in survival sex), female sex workers, transgender women and rape victims are at high risk for human papillomavirus (HPV) infection and consequently develop...

Human papillomavirus vaccines effectiveness to prevent genital warts: A population-base...
https://doi.org/10.1016/j.vaccine.2021.11.062
Vaccine Muñoz-Quiles C, López-Lacort M et. al.

Dec 7th, 2021 - To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women aged 14-23 years and to estimate the incidence of GW in the whole population aged from 14 to 65. Population-based retrospective cohort study using real-world...

Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndro...
https://doi.org/10.1016/j.vaccine.2021.11.046
Vaccine Duong CH, Mueller JE et. al.

Dec 7th, 2021 - The burden of human papillomavirus (HPV) infection can be substantially reduced through vaccination of girls, and gender-neutral policies are being adopted in many countries to accelerate disease control among women and expand direct benefits to m...

see more →

Guidelines  5 results

Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
https://doi.org/10.1097/AOG.0000000000004000
Obstetrics and Gynecology;

Aug 1st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Committee Opinion No. 704 Summary: Human Papillomavirus Vaccination.
https://doi.org/10.1097/AOG.0000000000002111
Obstetrics and Gynecology;

May 26th, 2017 - Human papillomavirus (HPV) is associated with anogenital cancer (including cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts. The HPV vaccination significantly reduces the incidence of anogenital cancer and geni...

Committee Opinion No. 704: Human Papillomavirus Vaccination.
https://doi.org/10.1097/AOG.0000000000002052
Obstetrics and Gynecology;

Mar 28th, 2017 - Human papillomavirus (HPV) is associated with anogenital cancer (including cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts. The HPV vaccination significantly reduces the incidence of anogenital cancer and geni...

Sexually transmitted diseases treatment guidelines, 2015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885289
MMWR. Recommendations and Reports : Morbidity and Mortali... Workowski KA, Bolan GA et. al.

Jun 5th, 2015 - These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30-M...

Committee opinion no. 588: human papillomavirus vaccination.
https://doi.org/10.1097/01.AOG.0000444458.00612.6b
Obstetrics and Gynecology;

Feb 21st, 2014 - The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that human papillomavirus (HPV) vaccination routinely be targeted to females and males aged 11 years or 12 years as part of the adolescen...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  29 results

Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study
https://clinicaltrials.gov/ct2/show/NCT05149248

Dec 8th, 2021 - Men who have sex with men (MSM), people with HIV, homeless people (many of whom participate in survival sex), female sex workers, transgender women and rape victims are at high risk for human papillomavirus (HPV) infection and consequently develop...

Community Pharmacists Vaccinate Against Cancer
https://clinicaltrials.gov/ct2/show/NCT04072159

Nov 9th, 2021 - Human papillomavirus (HPV) is the most common sexually transmitted infection, and persistent infection with oncogenic HPV strains causes cancer. Commercially available 9-valent HPV vaccines offer the potential of immunity against seven oncogenic s...

Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
https://clinicaltrials.gov/ct2/show/NCT03682601

Oct 8th, 2021 - Topical Veregen (15% sinecatechins) is an FDA approved botanical drug derived from green tea and is approved to be used as multiple doses, three times a day to treat all visible external genital warts. Topical green tea ointment has been shown to ...

Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC
https://clinicaltrials.gov/ct2/show/NCT03370406

Sep 14th, 2021 - Squamous cell carcinoma (SCC) of the lower extremity is a distinct subset of cutaneous squamous cell carcinomas which tend to occur multiply in elderly women. In contrast, the majority of cutaneous SCCs occur on the head and neck, and in men more ...

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
https://clinicaltrials.gov/ct2/show/NCT02119702

Aug 26th, 2021 - AMP Up aims to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition into adulthood. A group of perinatally HIV-exposed, -uninfected (PHEU) young adults from a similar s...

see more →

News  180 results

Study Suggests More Than Two-Thirds of Healthy Americans Are Infected with Human Papilloma Viruses
https://www.onclive.com/view/study-suggests-more-than-two-thirds-of-healthy-americans-are-infected-with-human-papilloma-viruses

Oct 6th, 2021 - In what is believed to be the largest and most detailed genetic analysis of its kind, researchers at NYU Langone Medical Center and elsewhere have concluded that 69 percent of healthy American adults are infected with one or more of 109 strains of...

HPV Vaccination Rates Continue to Climb Among Young Adults in US
https://www.medscape.com/viewarticle/950043

Apr 27th, 2021 - Although vaccination rates against the human papillomavirus (HPV) remain low for young adults across the United States, the number of self-reported HPV vaccinations among women and men between the ages of 18 and 21 years has markedly increased sin...

2021 Update on gynecologic cancer
https://www.mdedge.com/obgyn/article/237049/gynecologic-cancer
Shayan Dioun, MD, Jason D. Wright, MD

Mar 10th, 2021 - Gynecologic malignancies continue to be a major cause of cancer-related mortality in women. In 2020, a number of developments changed practice in gynecologic oncology.

Expert Differentiates Carcinogen-Induced and Virally Associated HNSCC
https://www.onclive.com/view/expert-differentiates-carcinogeninduced-and-virally-associated-hnscc

Dec 20th, 2020 - Kathryn A. Gold, MD Head and neck squamous cell carcinoma (HNSCC) consists of 2 biologically and clinically different diseases, according to Kathryn A. Gold, MD. The first of which is carcinogen induced, caused by tobacco or alcohol use, and the ...

Physician's Financial News: June 10, 2010
https://www.onclive.com/view/articles_pfn_jun2008

Dec 5th, 2020 - Click here to view as PDF. Seattle Genetics, Inc., Up and Coming Research-Based Concern, Developing Focused Pipeline of Targeted Therapies Seattle Genetics, Inc., is a clinical stage biotechnology company focused on the development and commercia...

see more →

Patient Education  18 results see all →